3 Defensive Stocks to Buy in September

3 Defensive Stocks to Buy in September

Analyzed Watch on YouTube Requested On
Video return
Calls
6
Buy / Sell
6 0
Published

Recommendations

Entry is the asset's closing price on the publication date. Current is the last close on record.

  1. 01 MDLZ NASDAQ BUY +0.00%
    Entry $62.42 09 Sep 2026
    Current $62.42 09 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    …US Market Strategist Dave Sekera pointed out that historically, September is the worst month for stocks. While he didn't predict a stock market downturn, he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International. Today, we're sharing three more defensive stocks to consider. These undervalued moat-y stocks may be more resilient if the market takes a turn for the worse. Our first undervalued defensive stock to buy this month is UnitedHealth Group. Th…

    His picks were Mondelez International, Alliant Energy, and Baxter International.

    AI-extracted context "he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International."

  2. 02 LNT NASDAQ BUY +0.00%
    Entry $67.86 09 Sep 2026
    Current $67.86 09 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    …US Market Strategist Dave Sekera pointed out that historically, September is the worst month for stocks. While he didn't predict a stock market downturn, he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International. Today, we're sharing three more defensive stocks to consider. These undervalued moat-y stocks may be more resilient if the market takes a turn for the worse. Our first undervalued defensive stock to buy this month is UnitedHealth Group. Th…

    His picks were Mondelez International, Alliant Energy, and Baxter International.

    AI-extracted context "he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International."

  3. 03 BAX NYSE BUY -0.86%
    Entry $24.39 09 Sep 2026
    Current $24.18 10 Sep 2026
    Result −$0.21
    vs. index −0.9% SPY +0.0% over the same days
    Surrounding source transcript
    …US Market Strategist Dave Sekera pointed out that historically, September is the worst month for stocks. While he didn't predict a stock market downturn, he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International. Today, we're sharing three more defensive stocks to consider. These undervalued moat-y stocks may be more resilient if the market takes a turn for the worse. Our first undervalued defensive stock to buy this month is UnitedHealth Group. Th…

    His picks were Mondelez International, Alliant Energy, and Baxter International.

    AI-extracted context "he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International."

  4. 04 UNH NYSE BUY +0.00%
    Entry $393.06 09 Sep 2026
    Current $393.06 09 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    … His picks were Mondelez International, Alliant Energy, and Baxter International. Today, we're sharing three more defensive stocks to consider. These undervalued moat-y stocks may be more resilient if the market takes a turn for the worse. Our first undervalued defensive stock to buy this month is UnitedHealth Group. This narrow moat company from the traditionally defensive healthcare sector operates a top-tier health insurer, pharmacy benefit manager, provider, and health analytics franchise. UnitedHealth has faced its share of challenges and headwind…

    Our first undervalued defensive stock to buy this month is UnitedHealth Group.

  5. 05 POR NYSE BUY +0.00%
    Entry $48.87 09 Sep 2026
    Current $48.87 09 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    …ent operations remain a concern. Yet, the company put up strong second-quarter results and lifted its outlook for 2026. Morningstar recently raised its fair value estimate on the stock by 11% to $475 per share. The stock looks undervalued. Our second undervalued stock to buy to play a little defense is from the utility sector. It's Portland General Electric. This narrow moat utility recently reached a settlement with Oregon regulators, allowing it to create a holding company structure, like most US utilities. Portland General could then finance investments outside its regulated utility, potent…

    Our second undervalued stock to buy to play a little defense is from the utility sector. It's Portland General Electric.

  6. 06 LW NYSE BUY +0.00%
    Entry $48.13 09 Sep 2026
    Current $48.13 09 Sep 2026
    Result +$0.00
    vs. index +0.0% SPY +0.0% over the same days
    Surrounding source transcript
    …vestments that would boost shareholder returns. We continue to forecast 7% annual earnings growth through 2029. The stock offers a nice yield above 4% to boot. We think Portland General is worth $56 per share and it trades well below that. Our final defensive stock to buy is Lamb Weston. This consumer defensive company is North America's largest producer of branded and private label frozen potato products. The firm primarily sells french fries to restaurants. Despite the current supply-demand imbalance, we view frozen proc…

    Our final defensive stock to buy is Lamb Weston.

Full Transcript
Hi, I'm Susan Jabinski, co-host of the Morning Filter podcast. On a recent episode, Morningstar Chief US Market Strategist Dave Sekera pointed out that historically, September is the worst month for stocks. While he didn't predict a stock market downturn, he did recommend three attractive stocks to buy from defensive sectors, just in case. His picks were Mondelez International, Alliant Energy, and Baxter International. Today, we're sharing three more defensive stocks to consider. These undervalued moat-y stocks may be more resilient if the market takes a turn for the worse. Our first undervalued defensive stock to buy this month is UnitedHealth Group. This narrow moat company from the traditionally defensive healthcare sector operates a top-tier health insurer, pharmacy benefit manager, provider, and health analytics franchise. UnitedHealth has faced its share of challenges and headwinds during the past few years, and regulatory challenges around its Medicare Advantage and pharmacy benefit management operations remain a concern. Yet, the company put up strong second-quarter results and lifted its outlook for 2026. Morningstar recently raised its fair value estimate on the stock by 11% to $475 per share. The stock looks undervalued. Our second undervalued stock to buy to play a little defense is from the utility sector. It's Portland General Electric. This narrow moat utility recently reached a settlement with Oregon regulators, allowing it to create a holding company structure, like most US utilities. Portland General could then finance investments outside its regulated utility, potentially allowing it to make acquisitions and growth investments that would boost shareholder returns. We continue to forecast 7% annual earnings growth through 2029. The stock offers a nice yield above 4% to boot. We think Portland General is worth $56 per share and it trades well below that. Our final defensive stock to buy is Lamb Weston. This consumer defensive company is North America's largest producer of branded and private label frozen potato products. The firm primarily sells french fries to restaurants. Despite the current supply-demand imbalance, we view frozen processed potatoes as positioned for cyclical recovery. In fact, we're already seeing early signs of recovery in the company's North American segment. And with management saying during its recent earnings call that capacity rationalization is happening industry-wide, we think Lamb Weston is at the beginning of an improved competitive environment. We assign Lamb Weston stock a $65 fair value estimate. For more stock ideas, be sure to tune into the Morning Filter each week wherever you get your podcasts and visit morningstar.com too.

Comments 0

No comments yet. Be the first to share your thoughts!